FDA Recall Open, Classified

DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361

Recall: Z-0921-2025 · Initiated October 7, 2024

Recall

Recall Number
Z-0921-2025
Event Number
95785
Firm
DRG International, Inc.
FEI Number
2245285
Product Code
CFP
Status
Open, Classified
Root Cause
Nonconforming Material/Component
Initiated
October 7, 2024
Posted
January 15, 2025
Address
841 Mountain Ave, Springfield, NJ, 07081-3437

Description

DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361

Reason

The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High) which causes a delay in results.

Action

DRG International began notifying consignees on 10/07/2024 via letter. Consignees were instructed to check inventory for affected units, cease use of them, and quarantine all product. Arrange return of those units. Consignees were also instructed to notify customers if units were further distributed.

Distribution

Worldwide - US Nationwide distribution in the state of New Jersey and the countries of Czechia and Romania.

Quantity

10 units